A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves' ophthalmopathy.
about
The evaluation and treatment of graves ophthalmopathyPlatelet-derived growth factor: a key factor in the pathogenesis of graves' ophthalmopathy and potential target for treatmentPingmu Decoction Induces Orbital Preadipocytes Apoptosis In Vitroβ-Arrestin-1 mediates thyrotropin-enhanced osteoblast differentiationPI3K/AKT pathway mediates induction of IL-1RA by TSH in fibrocytes: modulation by PTENRole of extrathyroidal TSHR expression in adipocyte differentiation and its association with obesityTargeting the thyroid-stimulating hormone receptor with small molecule ligands and antibodiesThe "TSH Receptor Glo Assay" - A High-Throughput Detection System for Thyroid Stimulation.A stimulatory thyrotropin receptor antibody enhances hyaluronic acid synthesis in graves' orbital fibroblasts: inhibition by an IGF-I receptor blocking antibody.Engineering Multi-Walled Carbon Nanotube Therapeutic Bionanofluids to Selectively Target Papillary Thyroid Cancer Cells.Immunopathogenesis of Graves' ophthalmopathy: the role of the TSH receptor.Forkhead Transcription Factor FOXO1 Is Regulated by Both a Stimulatory Thyrotropin Receptor Antibody and Insulin-Like Growth Factor-1 in Orbital Fibroblasts from Patients with Graves' Ophthalmopathy.A drug-like antagonist inhibits thyrotropin receptor-mediated stimulation of cAMP production in Graves' orbital fibroblasts.Mechanism of action of a nanomolar potent, allosteric antagonist of the thyroid-stimulating hormone receptorPentraxin-3 Is a TSH-Inducible Protein in Human Fibrocytes and Orbital Fibroblasts.The thyroid, the eyes and the gut: a possible connection.Association of IL12B polymorphisms with susceptibility to Graves ophthalmopathy in a Taiwan Chinese population.A small molecule antagonist inhibits thyrotropin receptor antibody-induced orbital fibroblast functions involved in the pathogenesis of Graves ophthalmopathy.Nicotinamide phosphoribosyltransferase leukocyte overexpression in Graves' opthalmopathyAllosteric modulators hit the TSH receptor.A modified ELISA accurately measures secretion of high molecular weight hyaluronan (HA) by Graves' disease orbital cells.Emerging pharmacotherapy for treatment of Graves' diseaseTotal thyroid ablation in Graves' orbitopathy.Pathogenesis of thyroid eye disease: review and update on molecular mechanisms.News and views: at long last, an animal model of Graves' orbitopathy.Proteomic analysis of the differences in orbital protein expression in thyroid orbitopathy.TSH/IGF-1 Receptor Cross-Talk Rapidly Activates Extracellular Signal-Regulated Kinases in Multiple Cell Types.Measuring TSH receptor antibody to influence treatment choices in Graves' disease.Anatomical, Physiological, and Functional Diversity of Adipose Tissue.Preoperative clinical features of reactivated of Graves' orbitopathy after orbital decompression.Changes of Nicotinamide Phosphoribosyltransferase Expressions in Thyroid Glands of Patients with Different Thyroid Pathologies.Combining micro-RNA and protein sequencing to detect robust biomarkers for Graves' disease and orbitopathy.
P2860
Q26862144-B4683BB2-4510-45BD-BB29-4454FF8D3BF2Q27005680-1CB5AA18-B2C6-4A3E-9CD2-5105D358A6FCQ33623928-442B4E03-206C-4318-995C-B16BA47ADC4EQ33913233-645A1574-D855-4978-98E3-108BFC3B13E7Q34131044-88796BEA-E481-4FB3-AD73-4646BEA96DC2Q35774768-DAA3F720-8E3D-4C9C-8CF7-D556C1608AD0Q35794921-EE662063-24F2-4358-8693-712A606EB91FQ35917939-08A51056-3A63-401B-A56B-9A8350490520Q35921348-C63FA70A-D2F1-4870-8EA1-F70A1B571565Q35931194-6EA9BF49-FC8F-4B65-80F4-3E0A1427766BQ35992560-FF6FF9A8-4DA6-4E81-832D-A91044538BD8Q36108611-CB7937F6-7839-41F8-8534-04810E47A907Q36124305-47DB74BD-7C7C-40CF-B8B2-4AC68B20F987Q36147341-683402E9-70E4-4EB9-9F51-E8D7C789D196Q36164346-20AEF37E-D3A2-438D-BECD-EDCFC0A30CDCQ36243615-78943C91-0237-48DF-B3F1-0DC167578739Q36444611-4CCC4A1C-73EF-4AEA-BF6F-B149CC00A7F5Q36817224-AC5AB8F4-EC2A-4260-81A0-B3D274AFBEC5Q37104648-42D3BF91-0291-447C-B8E5-4FB4DE232AABQ37405149-DB76C4B9-04B6-46B9-9BDA-073A0CE9C152Q37479329-EF50C48F-FF12-4757-985C-9D55F411CB7FQ37515491-02470BA2-AF81-48BF-8955-F359D4922A04Q38367695-EBACE074-303E-4E6C-8B97-07F5FFAE26BDQ38633022-1CAEEAA8-50B6-4D62-AB0A-0D117B3C33DBQ42562858-3E5397F2-7CD9-407E-A42D-717008649654Q47685471-3BF073A7-4F6A-4030-B53E-71BD18165E95Q47761035-DA281844-FBBE-4960-8946-2E28AC0BF5E8Q48125225-FF2D51D2-9282-4DA4-A61E-175B8E451FBDQ50103146-D3C4D27B-536D-46FA-B252-BBEE295190F1Q50967696-39892AF1-B40A-4908-9F1D-E9BF2C1D888AQ52726197-4E389E8F-008A-4EA6-B9F1-23E55556074DQ54962508-51EDE62B-AC5D-4B9F-A2A0-4CAE586981A1
P2860
A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves' ophthalmopathy.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A stimulatory TSH receptor ant ...... s with Graves' ophthalmopathy.
@ast
A stimulatory TSH receptor ant ...... s with Graves' ophthalmopathy.
@en
A stimulatory TSH receptor ant ...... s with Graves' ophthalmopathy.
@nl
type
label
A stimulatory TSH receptor ant ...... s with Graves' ophthalmopathy.
@ast
A stimulatory TSH receptor ant ...... s with Graves' ophthalmopathy.
@en
A stimulatory TSH receptor ant ...... s with Graves' ophthalmopathy.
@nl
prefLabel
A stimulatory TSH receptor ant ...... s with Graves' ophthalmopathy.
@ast
A stimulatory TSH receptor ant ...... s with Graves' ophthalmopathy.
@en
A stimulatory TSH receptor ant ...... s with Graves' ophthalmopathy.
@nl
P2093
P2860
P356
P1476
A stimulatory TSH receptor ant ...... ts with Graves' ophthalmopathy
@en
P2093
Michael Coenen
Rebecca S Bahn
Sarah Nadeem
Seema Kumar
P2860
P304
P356
10.1530/JME-11-0006
P577
2011-04-12T00:00:00Z